98%
921
2 minutes
20
Epilepsy surgery efficacy is critically contingent upon the precise localization of the epileptogenic zone (EZ). However, conventional qualitative methods face challenges in achieving accurate localization, integrating multimodal data, and accounting for variations in clinical expertise among practitioners. With the rapid advancement of artificial intelligence and computing power, multimodal quantitative analysis has emerged as a pivotal approach for EZ localization. Nonetheless, no research team has thus far provided a systematic elaboration of this concept. This narrative review synthesizes recent advancements across four key dimensions: (1) seizure semiology quantification using deep learning and computer vision to analyze behavioral patterns; (2) structural neuroimaging leveraging high-field MRI, radiomics, and AI; (3) functional imaging integrating EEG-fMRI dynamics and PET biomarkers; and (4) electrophysiological quantification encompassing source localization, intracranial EEG, and network modeling. The convergence of these complementary approaches enables comprehensive characterization of epileptogenic networks across behavioral, structural, functional, and electrophysiological domains. Despite these advancements, clinical heterogeneity, limitations in algorithmic generalizability, and barriers to data sharing hinder translation into clinical practice. Future directions emphasize personalized modeling, federated learning, and cross-modal standardization to advance data-driven localization. This integrated paradigm holds promise for overcoming qualitative limitations, reducing medical costs, and improving seizure-free outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00415-025-13324-5 | DOI Listing |
J Alzheimers Dis
September 2025
Department of Medicine and Surgery, Unit of Neurology, Neurophysiology, Neurobiology and Psychiatry, Università Campus Bio-Medico di Roma, Roma, Italy.
BackgroundAlzheimer's disease (AD) is the most common neurodegenerative disorder. While AD diagnosis traditionally relies on clinical criteria, recent trends favor a precise biological definition. Existing biomarkers efficiently detect AD pathology but inadequately reflect the extent of cognitive impairment or disease heterogeneity.
View Article and Find Full Text PDFVasa
September 2025
Angiology Department, Lausanne University Hospital, University of Lausanne, Switzerland.
Supervised exercise therapy (SET) is a first-line treatment for patients with symptomatic peripheral artery disease (PAD). However, its impact on inflammation, as well as the relationship between inflammation and functional improvements, remain poorly understood. In this prospective, single-arm study, 51 patients with symptomatic PAD underwent a 12-week multimodal SET program.
View Article and Find Full Text PDFNat Aging
September 2025
Aging Biomarker Consortium (ABC), Beijing, China.
The global surge in the population of people 60 years and older, including that in China, challenges healthcare systems with rising age-related diseases. To address this demographic change, the Aging Biomarker Consortium (ABC) has launched the X-Age Project to develop a comprehensive aging evaluation system tailored to the Chinese population. Our goal is to identify robust biomarkers and construct composite aging clocks that capture biological age, defined as an individual's physiological and molecular state, across diverse Chinese cohorts.
View Article and Find Full Text PDFIEEE Trans Neural Syst Rehabil Eng
September 2025
Force prediction is crucial for functional rehabilitation of the upper limb. Surface electromyography (sEMG) signals play a pivotal role in muscle force studies, but its non-stationarity challenges the reliability of sEMG-driven models. This problem may be alleviated by fusion with electrical impedance myography (EIM), an active sensing technique incorporating tissue morphology information.
View Article and Find Full Text PDFDiscov Nano
September 2025
Department of Rehabilitation Medicine, Rehabilitation Medical Center, Key Laboratory of Rehabilitation Medicine in Sichuan Province, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Immunoelectron Microscopy (IEM) is a technique that combines specific immunolabeling with high-resolution electron microscopic imaging to achieve precise spatial localization of biomolecules at the subcellular scale (< 10 nm) by using high-electron-density markers such as colloidal gold and quantum dots. As a core tool for analyzing the distribution of proteins, organelle interactions, and localization of disease pathology markers, it has irreplaceable value, especially in synapse research, pathogen-host interaction mechanism, and tumor microenvironment analysis. According to the differences in labeling sequence and sample processing, the IEM technology system can be divided into two categories: the first is pre-embedding labeling, which optimizes the labeling efficiency through the pre-exposure of antigenic epitopes and is especially suitable for the detection of low-abundance and sensitive antigens; the second is post-embedding labeling, which relies on the low-temperature resin embedding (e.
View Article and Find Full Text PDF